Cargando…
First Real-World, Multicenter, Post-Marketing, Retrospective Study of Dexamethasone Intraocular Suspension for Inflammation After Cataract Surgery
PURPOSE: To evaluate dexamethasone intraocular suspension 9% (intraocular DXM) in real-world clinical use to manage inflammation associated with cataract surgery. SETTING: Patients who underwent cataract surgery and received intraocular DXM at 22 outpatient eye surgery centers in the US. DESIGN: Ret...
Autores principales: | Bacharach, Jason, McCabe, Cathleen, Jackson, Mitchell, Rao, Sanjay, Singh, I Paul, Heersink, Sebastian, Radcliffe, Nathan, Weinstock, Robert, Paggiarino, Dario, Patel, Keyur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172921/ https://www.ncbi.nlm.nih.gov/pubmed/35685378 http://dx.doi.org/10.2147/OPTH.S357267 |
Ejemplares similares
-
Impact of dexamethasone intraocular suspension 9% on intraocular pressure after routine cataract surgery: post hoc analysis
por: Matossian, Cynthia, et al.
Publicado: (2020) -
Real-World Experience with Intracapsular Administration of Dexamethasone Intraocular Suspension 9% for Control of Postoperative Inflammation
por: McCabe, Cathleen, et al.
Publicado: (2022) -
Predictability of Intraocular Lens Power Calculation for Cataract with Keratoconus: A Multicenter Study
por: Kamiya, Kazutaka, et al.
Publicado: (2018) -
Clinical outcomes in a U.S. registration study of a new EDOF intraocular lens with a nondiffractive design
por: McCabe, Cathleen, et al.
Publicado: (2022) -
Cataract Surgery to Lower Intraocular Pressure
por: Berdahl, John P.
Publicado: (2009)